ArticleFrontiers in oncology2025

Frontline brentuximab vedotin-based therapy for newly diagnosed classical Hodgkin lymphoma: a meta-analysis of randomized controlled trials.

Yue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.